통합검색
내가 찾은 검색어
'HBV' 에 대한 통합검색결과 166건입니다.
한빛사166건
-
Ultrasensitive and long-lasting bioluminescence immunoassay for point-of-care viral antigen detection
- Nat. Biomed. Eng. May 30 2025, | https://doi.org/10.1038/s41551-025-01405-9
- 2025.05
- 바이오·의료융합
-
Amplification-free, OR-gated CRISPR-Cascade reaction for pathogen detection in blood samples
- Proc. Natl. Acad. Sci. USA March 10, 2025 | https://doi.org/10.1073/pnas.2420166122
- 2025.03
-
Male preference for TERT alterations and HBV integration in young-age HBV-related HCC: implications for sex disparity
- Clin. Mol. Hepatol. Jan 02 2025, | https://doi.org/10.3350/cmh.2024.0545
- 2025.01
- 의약학
-
Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized Trial
- Clin. Mol. Hepatol. Jan 17 2025, | https://doi.org/10.3350/cmh.2024.0819
- 2025.01
- 의약학
-
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or hig
- Lancet Gastroenterol. Hepatol. Jan 31 2025, S2468-1253(24)00431-X | https://doi.org/10.1016/S2468-1253(24)00431-X
- 2025.01
- 의약학
-
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
- Clin. Mol. Hepatol. Dec 26 2024, | https://doi.org/10.3350/cmh.2024.0824
- 2024.12
-
Advanced siRNA delivery in combating hepatitis B virus: mechanistic insights and recent updates
- J. Nanobiotechnol. Nov 30 2024, 22 (1) | https://doi.org/10.1186/s12951-024-03004-3
- 2024.11
- 의약학
-
[Correspondence] Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular
- Clin. Mol. Hepatol. Volume 30(4); Oct 2024 | https://doi.org/10.3350/cmh.2024.0368
- 2024.10
- 생명과학
-
Enhanced trans-cleavage activity using CRISPR-Cas12a variant designed to reduce steric inhibition by cis-cleavage products
- Biosens. Bioelectron. Oct 16 2024, 267 S0956-5663(24)00866-2 | https://doi.org/10.1016/j.bios.2024.116859
- 2024.10
-
Structural basis for hepatitis B virus restriction by a viral receptor homologue
- Nat. Commun. Oct 25 2024, 15 (1) 9241 | https://doi.org/10.1038/s41467-024-53533-6
- 2024.10
- 생명과학
-
Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation
- Clin. Mol. Hepatol. Oct 02 2024, | https://doi.org/10.3350/cmh.2024.0451
- 2024.10
- 의약학
-
Viral Load-Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B : A Multinational Study for the Develop
- Ann. Intern. Med. Sep 17 2024, | https://doi.org/10.7326/M24-0384
- 2024.09
- 의약학
-
-
Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B
- J. Hepatol. Aug 28 2024, S0168-8278(24)02488-7 | https://doi.org/10.1016/j.jhep.2024.08.010
- 2024.08
- 의약학
-
Baseline viral load and on-treatment hepatocellular carcinoma risk in chronic hepatitis B: A multinational cohort study
- Clin. Gastroenterol. Hepatol. Aug 22 2024, S1542-3565(24)00763-8 | https://doi.org/10.1016/j.cgh.2024.07.031
- 2024.08
- 의약학
-
[Correspondence] Reply to correspondence regarding “Class II Transactivator Restricts Viral Replication, Extending its Effect to HBV“
- Clin. Mol. Hepatol. 2024 Jul 17 | https://e-cmh.org/journal/view.php?doi=10.3350/cmh.2024.0572
- 2024.07
- 생명과학
-
Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab
- J. Hepatol. Jul 05 2024, S0168-8278(24)02333-X | https://doi.org/10.1016/j.jhep.2024.06.027
- 2024.07
-
[Editorial] Class II Transactivator Restricts Viral Replication, Extending its Effect to HBV
- Clin. Mol. Hepatol. Jul 03 2024, | https://doi.org/10.3350/cmh.2024.0465
- 2024.07
- 의약학
-
[Correspondence] Correspondence on Editorial regarding “Class II Transactivator Restricts Viral Replication and Extends Its Effect to HBV“.
- Clin. Mol. Hepatol. 2024 Jul 9 | https://www.e-cmh.org/journal/view.php?doi=10.3350/cmh.2024.0515
- 2024.07
- 의약학
-
Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
- Clin. Mol. Hepatol. Volume 30(3); Jul 2024 | https://doi.org/10.3350/cmh.2024.0042
- 2024.07
- 의약학
